Analysis of UBQLN1 variants in a polish Alzheimer's disease patient: Control series

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 4, 2008, Pages 366-371

  Golan, Maciej P ^a,d   Melquist, Stacey ^d   Safranow, Krzysztof ^b   Styczyńska, Maria ^a   Słowik, Agnieszka ^c   Kobryś, Małgorzata ^a   Zekanowski, Cezary ^a   Barcikowska, Maria ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Genetic association; Haplotypes; Single nucleotide polymorphism; Ubiquilin 1; UBQLN1

Indexed keywords

AGED; ALLELE; ALZHEIMER DISEASE; APOLIPOPROTEIN E4 GENE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; UBIQUILIN 1 GENE;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CARRIER PROTEINS; CELL CYCLE PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 42449130146     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121006     Document Type: Article

References (16)

1. Zekanowski C, Religa D, Graff C, Filipek S, Kuznicki J: Genetic aspects of Alzheimer's disease. Acta Neurobiol Exp (Wars) 2004;64:19-31.
2. Finckh U: The future of genetic association studies in Alzheimer disease. J Neural Transm 2003;110:253-266.
3. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE; NIMH Genetics Initiative Alzheimer's Disease Study Group. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003;12:23-32.
4. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J, Ramic D, Knowles H, Morris JC, Williams N, Norton N, Abraham R, Kehoe P, Williams H, Rudrasingham V, Rice F, Giles P, Tunstall N, Jones L, Lovestone S, Williams J, Owen MJ, Hardy J, Goate A: Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002;114:235-244.
5. Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, Elliott KJ, Velicelebi G, Moscarillo T, Hyman BT, Wagner SL, Becker KD, Blacker D, Tanzi RE: Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med 2005;352:884-894.
6. Kamboh MI, Minster RL, Feingold E, DeKosky ST: Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures. Mol Psychiatry 2006;11:273-279.
7. Slifer MA, Martin ER, Bronson PG, Browning-Large C, Doraiswamy PM, Welsh-Bohmer KA, Gilbert JR, Haines JL, Pericak-Vance MA: Lack of association between UBQLN1 and Alzheimer disease. Am J Med Genet B Neuropsychiatr Genet 2006;141:208-213.
8. Bensemain F, Chapuis J, Tian J, Shi J, Thaker U, Lendon C, Iwatsubo T, Amouyel P, Mann D, Lambert JC. Association study of the Ubiquilin gene with Alzheimer's disease. Neurobiol Dis 2006;22:691-693.
9. Smemo S, Nowotny P, Hinrichs AL, Kauwe JS, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM, Hollingworth P, O'Donovan MC, Morris CM, Holmans P, Lovestone S, Morris JC, Thal L, Li Y, Grupe A, Hardy J, Owen MJ, Williams J, Goate A: Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Ann Neurol 2006;59:21-26.
10. Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, van Duijn CM, De Deyn PP, Van Broeckhoven C, Dermaut B: The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years. Neurosci Lett 2006;392:72-74.
11. Arias-Vasquez A, de Lau L, Pardo L, Liu F, Feng BJ, Bertoli-Avella A, Isaacs A, Aulchenko Y, Hofman A, Oostra B, Breteler M, van Duijn C: Relationship of the ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function. Neurosci Lett 2007;424:1-5.
12. Styczynska M, Religa D, Pfeffer A, Luczywek E, Wasiak B, Styczynski G, Peplonska B, Gabryelewicz T, Golebiowski M, Kobrys M, Barcikowska M: Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003;344:99-102.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
14. Sasieni PD: From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-1261.
15. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434.
16. Thomas AV, Herl L, Spoelgen R, Hiltunen M, Jones PB, Tanzi RE, Hyman BT, Berezovska O: Interaction between presenilin 1 and ubiquilin 1 as detected by fluorescence lifetime imaging microscopy and a high throughput fluorescent plate reader. J Biol Chem 2006;281:26400-26407.